SCHEMBL5658511

SCHEMBL5658511

COC(=O)c1cc(OC)c(OC)c2oc(C(=O)c3ccc(OC)cc3)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
ALDH1A1 P00352 3/20 0.54
NPC1 O15118 3/20 0.54
HTT P42858 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
TUBB4A P04350 3/20 0.51
TUBB P07437 3/20 0.51
TUBA3C P0DPH7 3/20 0.51
TUBA1B P68363 3/20 0.51
TUBA4A P68366 3/20 0.51
TUBB4B P68371 3/20 0.51
TUBB3 Q13509 3/20 0.51
TUBB2A Q13885 3/20 0.51
TUBB8 Q3ZCM7 3/20 0.51
TUBA3E Q6PEY2 3/20 0.51
TUBA1A Q71U36 3/20 0.51
TUBA1C Q9BQE3 3/20 0.51
TUBB6 Q9BUF5 3/20 0.51
TUBB2B Q9BVA1 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5668947 0.90 SMN1; SMN2 (0.45) MAPTALDH1A1NPC1HTTRAB9A
SCHEMBL5659664 0.89 KMT2A (0.54) MAPTALDH1A1NPC1HTTRAB9A
SCHEMBL5659646 0.88 SMN1; SMN2 (0.47) MAPTALDH1A1NPC1HTTRAB9A
SCHEMBL5657121 0.81 MEN1 (0.43) ALDH1A1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5669321 0.81 KDM4E (0.49) MAPTALDH1A1HTTKDM4EPOLB
SCHEMBL5659291 0.79 MEN1 (0.41) MAPTALDH1A1NPC1RAB9ATUBB4A
SCHEMBL5657180 0.78 KDM4E (0.46) MAPTALDH1A1HTTKDM4EPOLB
SCHEMBL5655755 0.78 KDM4E (0.46) MAPTALDH1A1HTTSMN1; SMN2KDM4E
SCHEMBL5655693 0.77 KDM4E (0.45) MAPTALDH1A1HTTKDM4EPOLB
SCHEMBL5658605 0.76 KDM4E (0.44) MAPTALDH1A1SMN1; SMN2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR MAPT 3343/4885ALDH1A1 1365/4885NPC1 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.